Ms. Stafford was elected to our Board in March 2023. Ms. Stafford is currently Chief Financial Officer of Zymeworks Inc., a position she has held since April 2026. Prior this, she served as Senior Vice President, Chief Accounting Officer for Royalty Pharma plc, from December 2018 and as Vice President, Finance of Royalty Pharma and Chief Financial Officer of BioPharma Credit plc, an affiliate of Royal Pharma, from 2016 to 2018. Ms. Stafford is a Certified Public Accountant and holds a bachelor of science degree in business administration from Sonoma State University. Education: Sonoma State University, B.S. in Business Administration. Other Public Company Directorships: None. We believe that Ms. Stafford is qualified to serve on our Board because of her extensive financial expertise as a senior executive in the pharmaceutical industry and her earlier background as an accounting professional in other industries, including as a company controller and as an independent auditor.